Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons - PubMed
- ️Thu Jan 01 2004
Comparative Study
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons
Marco Pistis et al. Biol Psychiatry. 2004.
Abstract
Background: Recent studies have raised concerns about subtle long-lasting neurobiological changes that might be triggered by exposure to Cannabis derivatives, especially in a critical phase of brain maturation, such as puberty. The mesolimbic dopamine (DA) system, involved in the processing of drug-induced reward, is a locus of action of cannabinoids and endocannabinoids. Thus, we compared the effects of repeated cannabinoid administration in adolescent and adult rats on DA neuronal functions and responses to drugs of abuse.
Methods: Single-unit extracellular recordings from antidromically identified mesoaccumbens DA neurons and from their target cells in the nucleus accumbens were carried out in urethane-anesthetized rats. Animals were pretreated during adolescence or adulthood, for 3 days, with the cannabinoid agonist WIN55212.2 (WIN) or vehicle and allowed a 2-week interval.
Results: In cannabinoid-administered rats, DA neurons were significantly less responsive to the stimulating action of WIN, regardless of the age of pretreatment; however, in the adolescent group, but not in the adult, long-lasting cross-tolerance developed to morphine, cocaine, and amphetamine.
Conclusions: Our study suggests that an enduring form of neuronal adaptation occurs in DA neurons after subchronic cannabinoid intake at a young age, affecting subsequent responses to drugs of abuse.
Similar articles
-
Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Lecca S, et al. Neuropsychopharmacology. 2011 Feb;36(3):589-602. doi: 10.1038/npp.2010.190. Epub 2010 Nov 3. Neuropsychopharmacology. 2011. PMID: 21048703 Free PMC article.
-
Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Lecca S, et al. Neuropsychopharmacology. 2012 Apr;37(5):1164-76. doi: 10.1038/npp.2011.302. Epub 2011 Dec 14. Neuropsychopharmacology. 2012. PMID: 22169942 Free PMC article.
-
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
Szabo B, Siemes S, Wallmichrath I. Szabo B, et al. Eur J Neurosci. 2002 Jun;15(12):2057-61. doi: 10.1046/j.1460-9568.2002.02041.x. Eur J Neurosci. 2002. PMID: 12099913
-
Salmanzadeh H, Ahmadi-Soleimani SM, Pachenari N, Azadi M, Halliwell RF, Rubino T, Azizi H. Salmanzadeh H, et al. Brain Res Bull. 2020 Mar;156:105-117. doi: 10.1016/j.brainresbull.2020.01.007. Epub 2020 Jan 8. Brain Res Bull. 2020. PMID: 31926303 Review.
-
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods.
Viveros MP, Llorente R, Moreno E, Marco EM. Viveros MP, et al. Behav Pharmacol. 2005 Sep;16(5-6):353-62. doi: 10.1097/00008877-200509000-00007. Behav Pharmacol. 2005. PMID: 16148439 Review.
Cited by
-
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N. Liu CS, et al. CNS Drugs. 2015 Aug;29(8):615-23. doi: 10.1007/s40263-015-0270-y. CNS Drugs. 2015. PMID: 26271310 Review.
-
Brain activation to cannabis- and alcohol-related words in alcohol use disorder.
Müller-Oehring EM, Le Berre AP, Serventi M, Kalon E, Haas AL, Padula CB, Schulte T. Müller-Oehring EM, et al. Psychiatry Res Neuroimaging. 2019 Dec 30;294:111005. doi: 10.1016/j.pscychresns.2019.111005. Epub 2019 Nov 2. Psychiatry Res Neuroimaging. 2019. PMID: 31715379 Free PMC article.
-
Hammond CJ, Chaney A, Hendrickson B, Sharma P. Hammond CJ, et al. Int Rev Psychiatry. 2020 May;32(3):221-234. doi: 10.1080/09540261.2020.1713056. Epub 2020 Feb 6. Int Rev Psychiatry. 2020. PMID: 32026735 Free PMC article. Review.
-
Heterogeneity of dopamine neuron activity across traits and states.
Marinelli M, McCutcheon JE. Marinelli M, et al. Neuroscience. 2014 Dec 12;282:176-97. doi: 10.1016/j.neuroscience.2014.07.034. Epub 2014 Jul 30. Neuroscience. 2014. PMID: 25084048 Free PMC article. Review.
-
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Castaneto MS, et al. Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Epub 2014 Aug 18. Drug Alcohol Depend. 2014. PMID: 25220897 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous